{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:50:24Z","timestamp":1794473424335,"version":"4.9.1"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.critrevonc.2024.104311","type":"journal-article","created":{"date-parts":[[2024,3,3]],"date-time":"2024-03-03T10:32:56Z","timestamp":1709461976000},"page":"104311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["The cytokines in tumor microenvironment: from cancer initiation-elongation-progression to metastatic outgrowth"],"prefix":"10.1016","volume":"196","author":[{"given":"Rajalaxmi","family":"Pradhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anushka","family":"Kundu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanakya Nath","family":"Kundu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.critrevonc.2024.104311_bib1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3390\/cancers13020277","article-title":"The multiple potential biomarkers for predicting immunotherapy response-finding the needle in the haystack","volume":"13","author":"Adam","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.critrevonc.2024.104311_bib2","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.3390\/ijms21124449","article-title":"Cytokines and chemokines as mediators of prostate cancer metastasis","volume":"21","author":"Adekoya","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2024.104311_bib3","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1093\/pm\/pnx145","article-title":"Association of interleukin-6 and other cytokines with self-reported pain in prostate cancer patients receiving chemotherapy","volume":"19","author":"Al-Mazidi","year":"2018","journal-title":"Pain. Med."},{"key":"10.1016\/j.critrevonc.2024.104311_bib4","doi-asserted-by":"crossref","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","article-title":"The tumor microenvironment","volume":"30","author":"Anderson","year":"2020","journal-title":"Curr. Biol."},{"key":"10.1016\/j.critrevonc.2024.104311_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-018-0426-4","article-title":"Cancer stem cells as key drivers of tumour progression","volume":"25","author":"Ayob","year":"2018","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.critrevonc.2024.104311_bib6","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s40263-019-00623-5","article-title":"Revisiting tramadol: a multi-modal agent for pain management","volume":"33","author":"Barakat","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.critrevonc.2024.104311_bib7","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41577-019-0147-2","article-title":"Pain and immunity: implications for host defence","volume":"19","author":"Baral","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.critrevonc.2024.104311_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-3-030-32656-2_2","article-title":"Dietary carcinogens and DNA adducts in prostate cancer","author":"Bellamri","year":"2019","journal-title":"Prostate Cancer.: Cell. Genet. Mech. Dis. Dev. Progress."},{"key":"10.1016\/j.critrevonc.2024.104311_bib9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41698-017-0038-6","article-title":"The therapeutic potential of resveratrol: a review of clinical trials","volume":"1","author":"Berman","year":"2017","journal-title":"NPJ Precis. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104311_bib10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41416-018-0328-y","article-title":"Cytokines in clinical cancer immunotherapy","volume":"120","author":"Berraondo","year":"2019","journal-title":"Br. J. Cancer"},{"issue":"46","key":"10.1016\/j.critrevonc.2024.104311_bib11","doi-asserted-by":"crossref","first-page":"28960","DOI":"10.1073\/pnas.2013644117","article-title":"CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response","volume":"117","author":"Biasci","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.critrevonc.2024.104311_bib12","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/PPO.0000000000000138","article-title":"The contribution of angiogenesis to the process of metastasis","volume":"21","author":"Bielenberg","year":"2015","journal-title":"Cancer J."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104311_bib13","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s40425-019-0706-x","article-title":"Phase I trial of HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors","volume":"7","author":"Bilusic","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.critrevonc.2024.104311_bib14","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41568-021-00363-z","article-title":"Interleukins in cancer: from biology to therapy","volume":"21","author":"Briukhovetska","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2024.104311_bib15","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.3390\/molecules25184292","article-title":"Resveratrol suppresses cross-talk between colorectal cancer cells and stromal cells in multicellular tumor microenvironment: a bridge between in vitro and in vivo tumor microenvironment study","volume":"25","author":"Buhrmann","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.critrevonc.2024.104311_bib16","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10875-012-9847-0","article-title":"Cancer-related inflammation","volume":"33","author":"Candido","year":"2013","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.critrevonc.2024.104311_bib17","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.omtn.2020.04.002","article-title":"The interplay among miRNAs, major cytokines, and cancer-related inflammation","volume":"20","author":"Chakraborty","year":"2020","journal-title":"Mol. Ther. -Nucleic Acids"},{"key":"10.1016\/j.critrevonc.2024.104311_bib18","doi-asserted-by":"crossref","DOI":"10.3892\/or.2019.7206","article-title":"IL-10 secreted by cancer-associated macrophages regulates proliferation and invasion in gastric cancer cells via c-Met\/STAT3 signaling","author":"Chen","year":"2019","journal-title":"Oncol. Rep. 42, 595\u2013604"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104311_bib19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12885-018-5025-y","article-title":"Sleep duration and the risk of cancer: a systematic review and meta-analysis including dose\u2013response relationship","volume":"18","author":"Chen","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2024.104311_bib20","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.2147\/OTT.S168317","article-title":"Tumor-associated macrophage-derived cytokines enhance cancer stem-like characteristics through epithelial\u2013mesenchymal transition.","author":"Chen","year":"2018","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.critrevonc.2024.104311_bib21","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3390\/biomedicines10030713","article-title":"Natural compounds targeting cancer-associated fibroblasts against digestive system tumor progression: therapeutic insights","volume":"10","author":"Chiu","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.critrevonc.2024.104311_bib22","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fcell.2020.00402","article-title":"Molecular aspects and future perspectives of cytokine-based anti-cancer immunotherapy","volume":"8","author":"Chulpanova","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.critrevonc.2024.104311_bib23","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.10817.1","article-title":"Recent advances in understanding and managing cancer pain","volume":"6","author":"Chwistek","year":"2017","journal-title":"F1000Research"},{"key":"10.1016\/j.critrevonc.2024.104311_bib24","series-title":"Cancer: The Enemy from Within: A Comprehensive Textbook of Cancer\u2019s Causes, Complexities and Consequences","author":"Compton","year":"2020"},{"key":"10.1016\/j.critrevonc.2024.104311_bib25","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1089\/jir.2018.0019","article-title":"Cytokines in the treatment of cancer","volume":"39","author":"Conlon","year":"2019","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.critrevonc.2024.104311_bib26","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.it.2017.12.003","article-title":"Immune cytokines and their receptors in inflammatory pain","volume":"39","author":"Cook","year":"2018","journal-title":"Trends Immunol."},{"key":"10.1016\/j.critrevonc.2024.104311_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13402-019-00489-1","article-title":"The dual role of tumor necrosis factor-alpha (TNF-\u03b1) in breast cancer: molecular insights and therapeutic approaches","volume":"43","author":"Cruceriu","year":"2020","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.critrevonc.2024.104311_bib28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0034-7094(11)70029-0","article-title":"Cytokines and pain","volume":"61","author":"de Oliveira","year":"2011","journal-title":"Braz. J. Anesthesiol."},{"key":"10.1016\/j.critrevonc.2024.104311_bib29","doi-asserted-by":"crossref","DOI":"10.21037\/atm.2019.09.68","article-title":"Inflammation, immunosuppressive microenvironment and breast cancer: opportunities for cancer prevention and therapy","volume":"7","author":"Deshmukh","year":"2019","journal-title":"Ann. Transl. Med."},{"issue":"10","key":"10.1016\/j.critrevonc.2024.104311_bib30","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1093\/annonc\/mdv309","article-title":"A phase I trial combining carboplatin\/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-\u03b12b in patients with recurrent epithelial ovarian cancer","volume":"26","author":"Dijkgraaf","year":"2015","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2024.104311_bib31","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s10555-012-9375-7","article-title":"TGF-\u03b2 signalling and its role in cancer progression and metastasis","volume":"31","author":"Drabsch","year":"2012","journal-title":"Cancer Metastas\u00a0Rev."},{"key":"10.1016\/j.critrevonc.2024.104311_bib32","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0885-3924(00)00199-8","article-title":"Cytokines and advanced cancer","volume":"20","author":"Dunlop","year":"2000","journal-title":"J. Pain. Symptom Manag."},{"key":"10.1016\/j.critrevonc.2024.104311_bib33","first-page":"50","article-title":"Cytokines regulation and role in modulating cancer related","author":"Faisal","year":"2019","journal-title":"Pain: A Brief. Overv. Med. Clin. Res. Rep."},{"key":"10.1016\/j.critrevonc.2024.104311_bib34","doi-asserted-by":"crossref","first-page":"9095","DOI":"10.1007\/s13277-015-3973-2","article-title":"N-Methyl-N-nitrosourea as a mammary carcinogenic agent","volume":"36","author":"Faustino-Rocha","year":"2015","journal-title":"Tumor Biol."},{"key":"10.1016\/j.critrevonc.2024.104311_bib35","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.3390\/ijms20184413","article-title":"Immune and inflammatory cells in thyroid cancer microenvironment","volume":"20","author":"Ferrari","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2024.104311_bib36","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99911","article-title":"The evolving relationship of wound healing and tumor stroma","volume":"3","author":"Foster","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.critrevonc.2024.104311_bib37","doi-asserted-by":"crossref","first-page":"a028662","DOI":"10.1101\/cshperspect.a028662","article-title":"Cancer inflammation and cytokines","volume":"10","author":"Galdiero","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.critrevonc.2024.104311_bib38","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.3390\/cancers14102446","article-title":"Role of cytokines and chemokines in angiogenesis in a tumor context","volume":"14","author":"Geindreau","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2024.104311_bib39","doi-asserted-by":"crossref","first-page":"6009","DOI":"10.3390\/ijms21176009","article-title":"Roles of IL-1 in cancer: from tumor progression to resistance to targeted therapies","volume":"21","author":"Gelfo","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2024.104311_bib40","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1101\/gad.314617.118","article-title":"Roles of the immune system in cancer: from tumor initiation to metastatic progression","volume":"32","author":"Gonzalez","year":"2018","journal-title":"Genes Dev."},{"key":"10.1016\/j.critrevonc.2024.104311_bib41","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2024.104311_bib42","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3390\/ijms20040925","article-title":"Resveratrol as a tumor-suppressive nutraceutical modulating tumor microenvironment and malignant behaviors of cancer","volume":"20","author":"Han","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2024.104311_bib43","doi-asserted-by":"crossref","first-page":"v231","DOI":"10.1093\/annonc\/mdz246.090","article-title":"Phase I\/II study with CXCL12 inhibitor NOX-A12 and pembrolizumab in patients with microsatellite-stable, metastatic colorectal or pancreatic cancer","volume":"30","author":"Halama","year":"2019","journal-title":"Ann. Oncol."},{"issue":"7","key":"10.1016\/j.critrevonc.2024.104311_bib44","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/jn\/nxz029","article-title":"Curcumin combined with FOLFOX chemotherapy is safe and tolerable in patients with metastatic colorectal cancer in a randomized phase IIa trial","volume":"149","author":"Howells","year":"2019","journal-title":"J. Nutr."},{"key":"10.1016\/j.critrevonc.2024.104311_bib45","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc.2016.73","article-title":"The biology and function of fibroblasts in cancer","volume":"16","author":"Kalluri","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2024.104311_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.692142","article-title":"Tumor-induced inflammatory cytokines and the emerging diagnostic devices for cancer detection and prognosis","volume":"11","author":"Kartikasari","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2024.104311_bib47","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1080\/01635581.2016.1158295","article-title":"Resveratrol prevents tumor growth and metastasis by inhibiting lymphangiogenesis and M2 macrophage activation and differentiation in tumor-associated macrophages","volume":"68","author":"Kimura","year":"2016","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.critrevonc.2024.104311_bib48","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1426519","article-title":"M7824, a novel bifunctional anti-PD-L1\/TGFbeta Trap fusion protein, promotes anti-tumor efficacy as monotherapy and in combination with vaccine","volume":"7","author":"Knudson","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.critrevonc.2024.104311_bib49","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s12016-019-08753-w","article-title":"Role of mast cells in shaping the tumor microenvironment","volume":"58","author":"Komi","year":"2020","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.critrevonc.2024.104311_bib50","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1172\/JCI57099","article-title":"Breast cancer stem cells, cytokine networks, and the tumor microenvironment","volume":"121","author":"Korkaya","year":"2011","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.critrevonc.2024.104311_bib51","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1002\/1097-0142(20010915)92:6+<1684::AID-CNCR1497>3.0.CO;2-Z","article-title":"The role of cytokines in cancer-related fatigue","volume":"92","author":"Kurzrock","year":"2001","journal-title":"Cancer: Interdiscip. Int. J. Am. Cancer Soc."},{"key":"10.1016\/j.critrevonc.2024.104311_bib52","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.jpainsymman.2018.01.008","article-title":"The role of inflammation in the pain, fatigue, and sleep disturbance symptom cluster in advanced cancer","volume":"55","author":"Kwekkeboom","year":"2018","journal-title":"J. Pain. Symptom Manag."},{"key":"10.1016\/j.critrevonc.2024.104311_bib53","doi-asserted-by":"crossref","first-page":"940","DOI":"10.3389\/fimmu.2020.00940","article-title":"The tumor microenvironment: a milieu hindering and obstructing antitumor immune responses","volume":"11","author":"Labani-Motlagh","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2024.104311_bib54","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3390\/cells10010100","article-title":"Inflammatory cytokines in cancer: comprehensive understanding and clinical progress in gene therapy","volume":"10","author":"Lan","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.critrevonc.2024.104311_bib55","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/149185","article-title":"Chronic inflammation and cytokines in the tumor microenvironment","volume":"2014","author":"Landskron","year":"2014","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.critrevonc.2024.104311_bib56","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000079408","article-title":"A cytokine-based neuroimmunologic mechanism of cancer-related symptoms","volume":"11","author":"Lee","year":"2004","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.critrevonc.2024.104311_bib57","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.3390\/cancers3043856","article-title":"Cytokines in cancer immunotherapy","volume":"3","author":"Lee","year":"2011","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2024.104311_bib58","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001341","article-title":"Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer","volume":"9","author":"Li","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.critrevonc.2024.104311_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106939","article-title":"Effects of immune cells and cytokines on inflammation and immunosuppression in the tumor microenvironment","volume":"88","author":"Li","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104311_bib60","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.joim.2021.02.001","article-title":"Effects of moxibustion on Treg cells in sarcoma microenvironment","volume":"19","author":"Li","year":"2021","journal-title":"J. Integr. Med"},{"key":"10.1016\/j.critrevonc.2024.104311_bib61","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.3390\/pharmaceutics14122606","article-title":"Cytokine Therapy Combined with Nanomaterials Participates in Cancer Immunotherapy","volume":"14","author":"Lian","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.critrevonc.2024.104311_bib62","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1172\/JCI31537","article-title":"A cytokine-mediated link between innate immunity, inflammation, and cancer","volume":"117","author":"Lin","year":"2007","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.critrevonc.2024.104311_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-019-0760-3","article-title":"Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications","volume":"12","author":"Lin","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.critrevonc.2024.104311_bib64","first-page":"67","article-title":"Cytokine networks and cancer stem cells","author":"Liongue","year":"2015","journal-title":"Cancer Stem Cells.: Emerg. Concepts Future Perspect. Transl. Oncol."},{"key":"10.1016\/j.critrevonc.2024.104311_bib65","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s40487-018-0089-z","article-title":"The role of interleukin-1 in the pathogenesis of cancer and its potential as a therapeutic target in clinical practice","volume":"6","author":"Litmanovich","year":"2018","journal-title":"Oncol. Ther."},{"key":"10.1016\/j.critrevonc.2024.104311_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-019-0770-1","article-title":"Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy","volume":"12","author":"Liu","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.critrevonc.2024.104311_bib67","doi-asserted-by":"crossref","first-page":"11405","DOI":"10.1021\/acsomega.2c00571","article-title":"M1 macrophages enhance survival and invasion of oral squamous cell carcinoma by inducing GDF15-mediated ErbB2 phosphorylation","volume":"7","author":"Lv","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.critrevonc.2024.104311_bib68","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumour-associated macrophages as treatment targets in oncology","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2024.104311_bib69","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nrc747","article-title":"Molecular mechanisms of cancer pain","volume":"2","author":"Mantyh","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2024.104311_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.688489","article-title":"A double-edged sword role of cytokines in prostate cancer immunotherapy","volume":"11","author":"Mao","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2024.104311_bib71","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10555-012-9415-3","article-title":"Stromal cells in tumor microenvironment and breast cancer","volume":"32","author":"Mao","year":"2013","journal-title":"Cancer Metastas-.-. Rev."},{"key":"10.1016\/j.critrevonc.2024.104311_bib72","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.3389\/fonc.2019.01146","article-title":"Tumor associated neutrophils. Their role in tumorigenesis, metastasis, prognosis and therapy","volume":"9","author":"Masucci","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2024.104311_bib73","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.3390\/cancers13133225","article-title":"Immune circuits to shape natural killer cells in cancer","volume":"13","author":"Mattiola","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2024.104311_bib74","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.3389\/fimmu.2019.03038","article-title":"Influence of the tumor microenvironment on NK cell function in solid tumors","volume":"10","author":"Melaiu","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2024.104311_bib75","doi-asserted-by":"crossref","first-page":"919","DOI":"10.3390\/cells9040919","article-title":"Signaling of macrophages that contours the tumor microenvironment for promoting cancer development","volume":"9","author":"Messex","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.critrevonc.2024.104311_bib76","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.3389\/fimmu.2019.01835","article-title":"The dark side of fibroblasts: cancer-associated fibroblasts as mediators of immunosuppression in the tumor microenvironment","author":"Monteran","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2024.104311_bib77","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3390\/cancers12030673","article-title":"Natural compounds with potential to modulate cancer therapies and self-reactive immune cells","volume":"12","author":"Moody","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2024.104311_bib78","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1939-1676.2011.00836.x","article-title":"Inflammation and cancer: a comparative view","volume":"26","author":"Morrison","year":"2012","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.critrevonc.2024.104311_bib79","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fimmu.2011.00098","article-title":"Chronic inflammation in cancer development","volume":"2","author":"Multhoff","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2024.104311_bib80","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3389\/fcell.2020.00766","article-title":"Tumor endothelial cells (TECs) as potential immune directors of the tumor microenvironment\u2013new findings and future perspectives","volume":"8","author":"Nagl","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.critrevonc.2024.104311_bib81","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/S1470-2045(19)30514-5","article-title":"Pegilodecakin combined with pembrolizumab or nivolumab for patients with advanced solid tumours (IVY): a multicentre, multicohort, open-label, phase 1b trial","volume":"20","author":"Naing","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2024.104311_bib82","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/S1470-2045(19)30514-5","article-title":"Pegilodecakin combined with pembrolizumab or nivolumab for patients with advanced solid tumours (IVY): a multicentre, multicohort, open-label, phase 1b trial","volume":"20","author":"Naing","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2024.104311_bib83","first-page":"4584","article-title":"Chemokine-cytokine networks in the head and neck tumor microenvironment","volume":"22","author":"Nisar","year":"2021"},{"key":"10.1016\/j.critrevonc.2024.104311_bib84","series-title":"StatPearls","article-title":"Anorexia and Cachexia","author":"Ohnuma","year":"2024"},{"key":"10.1016\/j.critrevonc.2024.104311_bib85","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.molimm.2014.02.020","article-title":"Mast cells as targets for immunotherapy of solid tumors","volume":"63","author":"Oldford","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.critrevonc.2024.104311_bib86","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4273943","article-title":"The immune system in cancer pathogenesis: potential therapeutic approaches","volume":"2016","author":"Pandya","year":"2016","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.critrevonc.2024.104311_bib87","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177620","article-title":"The relationship between pro-inflammatory cytokines and pain, appetite and fatigue in patients with advanced cancer","volume":"12","author":"Paulsen","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.critrevonc.2024.104311_bib88","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3389\/fimmu.2018.00563","article-title":"Immunological approaches towards cancer and inflammation: a cross talk","volume":"9","author":"Qu","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2024.104311_bib89","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3390\/genes11040409","article-title":"Replication stress, DNA damage, inflammatory cytokines and innate immune response","volume":"11","author":"Ragu","year":"2020","journal-title":"Genes"},{"key":"10.1016\/j.critrevonc.2024.104311_bib90","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1268331","article-title":"Potential biomarkers for predicting immune response and outcomes in lung cancer patients undergoing thermal ablation","volume":"14","author":"Sang","year":"2023","journal-title":"Front Immunol."},{"key":"10.1016\/j.critrevonc.2024.104311_bib91","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3389\/fonc.2020.00324","article-title":"Macrophage and tumor cell cross-talk is fundamental for lung tumor progression: we need to talk","volume":"10","author":"Sarode","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2024.104311_bib92","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.734188","article-title":"The recruitment of neutrophils to the tumor microenvironment is regulated by multiple mediators","volume":"12","author":"SenGupta","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2024.104311_bib93","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nrc2507","article-title":"Cytokines and their relationship to the symptoms and outcome of cancer","volume":"8","author":"Seruga","year":"2008","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104311_bib94","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40425-018-0343-9","article-title":"Cytokine release syndrome","volume":"6","author":"Shimabukuro-Vornhagen","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.critrevonc.2024.104311_bib95","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/jox11010002","article-title":"The effects of resveratrol on prostate cancer through targeting the tumor microenvironment","volume":"11","author":"Silk","year":"2021","journal-title":"J. Xenobiotics"},{"key":"10.1016\/j.critrevonc.2024.104311_bib96","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.3389\/fimmu.2017.01106","article-title":"Translational significance for tumor metastasis of tumor-associated macrophages and epithelial\u2013mesenchymal transition","volume":"8","author":"Song","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2024.104311_bib97","article-title":"The emerging roles of pericytes in modulating tumor microenvironment","volume":"9","author":"Sun","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.critrevonc.2024.104311_bib98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-8722-5-63","article-title":"Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy","volume":"5","author":"Sun","year":"2012","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.critrevonc.2024.104311_bib99","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41571-018-0007-1","article-title":"Targeting the tumour stroma to improve cancer therapy","volume":"15","author":"Valkenburg","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2024.104311_bib100","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/984570","article-title":"Treatment of cancer pain by targeting cytokines","volume":"2015","author":"Vendrell","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.critrevonc.2024.104311_bib101","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0140-6736(13)62224-2","article-title":"Global cancer patterns: causes and prevention","volume":"383","author":"Vineis","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2024.104311_bib102","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von Hoff","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104311_bib103","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41392-022-01136-2","article-title":"Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.critrevonc.2024.104311_bib104","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1002\/cam4.2327","article-title":"Crosstalk between cancer and immune cells: Role of tumor-associated macrophages in the tumor microenvironment","volume":"8","author":"Wang","year":"2019","journal-title":"Cancer Med."},{"key":"10.1016\/j.critrevonc.2024.104311_bib105","doi-asserted-by":"crossref","first-page":"761","DOI":"10.7150\/jca.17648","article-title":"Role of tumor microenvironment in tumorigenesis","volume":"8","author":"Wang","year":"2017","journal-title":"J. Cancer"},{"key":"10.1016\/j.critrevonc.2024.104311_bib106","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.601738","article-title":"Nerves in the tumor microenvironment: origin and effects","volume":"8","author":"Wang","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.critrevonc.2024.104311_bib107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-018-0815-2","article-title":"M1-like tumor-associated macrophages activated by exosome-transferred THBS1 promote malignant migration in oral squamous cell carcinoma","volume":"37","author":"Xiao","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2024.104311_bib108","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.3389\/fimmu.2020.01371","article-title":"Myeloid-derived suppressor cells in tumors: from mechanisms to antigen specificity and microenvironmental regulation","volume":"11","author":"Yang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2024.104311_bib109","doi-asserted-by":"crossref","first-page":"5","DOI":"10.31557\/apjec.2018.1.1.5-13","article-title":"Occupational and environmental cancer","volume":"1","author":"Yari","year":"2018","journal-title":"Asian Pac. J. Environ. Cancer"},{"key":"10.1016\/j.critrevonc.2024.104311_bib110","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.3892\/or.2016.4660","article-title":"Role of the tumor microenvironment in tumor progression and the clinical applications","volume":"35","author":"Yuan","year":"2016","journal-title":"Oncol. Rep."},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104311_bib111","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3736\/jcim20100303","article-title":"Discussion of the correlation between phlegm and tumor microenvironment","volume":"8","author":"Zhang","year":"2010","journal-title":"Zhong Xi Yi Jie He Xue Bao."},{"key":"10.1016\/j.critrevonc.2024.104311_bib112","first-page":"679","article-title":"Interplay between inflammatory tumor microenvironment and cancer stem cells","volume":"16","author":"Zhang","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.critrevonc.2024.104311_bib113","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.apsb.2020.08.010","article-title":"Nanomedicines modulating tumor immunosuppressive cells to enhance cancer immunotherapy","volume":"10","author":"Zhu","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.critrevonc.2024.104311_bib114","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.3389\/fimmu.2019.01643","article-title":"M1 macrophages induce PD-L1 expression in hepatocellular carcinoma cells through IL-1\u03b2 signaling","volume":"10","author":"Zong","year":"2019","journal-title":"Front. Immunol."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842824000544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842824000544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T13:41:03Z","timestamp":1715434863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842824000544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":114,"alternative-id":["S1040842824000544"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2024.104311","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The cytokines in tumor microenvironment: from cancer initiation-elongation-progression to metastatic outgrowth","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2024.104311","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104311"}}